BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 11583632)

  • 1. Involvement of PIAS1 in the sumoylation of tumor suppressor p53.
    Kahyo T; Nishida T; Yasuda H
    Mol Cell; 2001 Sep; 8(3):713-8. PubMed ID: 11583632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.
    Schmidt D; Müller S
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2872-7. PubMed ID: 11867732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIAS1 enhances SUMO-1 modification and the transactivation activity of the major immediate-early IE2 protein of human cytomegalovirus.
    Lee JM; Kang HJ; Lee HR; Choi CY; Jang WJ; Ahn JH
    FEBS Lett; 2003 Dec; 555(2):322-8. PubMed ID: 14644436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.
    Wang J; Qin H; Liang J; Zhu Y; Liang L; Zheng M; Han H
    J Mol Biol; 2007 Jun; 370(1):27-38. PubMed ID: 17509614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a non-covalent ternary complex formed by PIAS1, SUMO1, and UBC9 proteins involved in transcriptional regulation.
    Mascle XH; Lussier-Price M; Cappadocia L; Estephan P; Raiola L; Omichinski JG; Aubry M
    J Biol Chem; 2013 Dec; 288(51):36312-27. PubMed ID: 24174529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of interactions of human cytomegalovirus immediate-early IE2 regulatory protein with small ubiquitin-like modifiers and their conjugation enzyme Ubc9.
    Ahn JH; Xu Y; Jang WJ; Matunis MJ; Hayward GS
    J Virol; 2001 Apr; 75(8):3859-72. PubMed ID: 11264375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR structure of the N-terminal domain of SUMO ligase PIAS1 and its interaction with tumor suppressor p53 and A/T-rich DNA oligomers.
    Okubo S; Hara F; Tsuchida Y; Shimotakahara S; Suzuki S; Hatanaka H; Yokoyama S; Tanaka H; Yasuda H; Shindo H
    J Biol Chem; 2004 Jul; 279(30):31455-61. PubMed ID: 15133049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of yeast PIAS-type SUMO ligases in vivo and in vitro.
    Takahashi Y; Toh-E A; Kikuchi Y
    J Biochem; 2003 Apr; 133(4):415-22. PubMed ID: 12761287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of protein inhibitor of activated STAT1 (PIAS1) by MAPK-activated protein kinase-2 inhibits endothelial inflammation via increasing both PIAS1 transrepression and SUMO E3 ligase activity.
    Heo KS; Chang E; Takei Y; Le NT; Woo CH; Sullivan MA; Morrell C; Fujiwara K; Abe J
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):321-9. PubMed ID: 23202365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMO-1 modification activates the transcriptional response of p53.
    Rodriguez MS; Desterro JM; Lain S; Midgley CA; Lane DP; Hay RT
    EMBO J; 1999 Nov; 18(22):6455-61. PubMed ID: 10562557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIAS1 and PIASxalpha function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription.
    Nishida T; Yasuda H
    J Biol Chem; 2002 Nov; 277(44):41311-7. PubMed ID: 12177000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of p53 by protein inhibitor of activated Stat1 (PIAS1).
    Megidish T; Xu JH; Xu CW
    J Biol Chem; 2002 Mar; 277(10):8255-9. PubMed ID: 11788578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubc9 fusion-directed SUMOylation (UFDS): a method to analyze function of protein SUMOylation.
    Jakobs A; Koehnke J; Himstedt F; Funk M; Korn B; Gaestel M; Niedenthal R
    Nat Methods; 2007 Mar; 4(3):245-50. PubMed ID: 17277783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional activity of peroxisome proliferator-activated receptor gamma is modulated by SUMO-1 modification.
    Ohshima T; Koga H; Shimotohno K
    J Biol Chem; 2004 Jul; 279(28):29551-7. PubMed ID: 15123625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a substrate recognition site on Ubc9.
    Lin D; Tatham MH; Yu B; Kim S; Hay RT; Chen Y
    J Biol Chem; 2002 Jun; 277(24):21740-8. PubMed ID: 11877416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Mdm-2 amino terminus is required for Mdm2 binding and SUMO-1 conjugation by the E2 SUMO-1 conjugating enzyme Ubc9.
    Buschmann T; Lerner D; Lee CG; Ronai Z
    J Biol Chem; 2001 Nov; 276(44):40389-95. PubMed ID: 11384992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Ubc9, an E2 ligase for SUMO conjugation, with p53 is regulated by phosphorylation of p53.
    Lin JY; Ohshima T; Shimotohno K
    FEBS Lett; 2004 Aug; 573(1-3):15-8. PubMed ID: 15327968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIAS1-mediated sumoylation of focal adhesion kinase activates its autophosphorylation.
    Kadaré G; Toutant M; Formstecher E; Corvol JC; Carnaud M; Boutterin MC; Girault JA
    J Biol Chem; 2003 Nov; 278(48):47434-40. PubMed ID: 14500712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necdin promotes ubiquitin-dependent degradation of PIAS1 SUMO E3 ligase.
    Gur I; Fujiwara K; Hasegawa K; Yoshikawa K
    PLoS One; 2014; 9(6):e99503. PubMed ID: 24911587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases.
    Kotaja N; Karvonen U; Jänne OA; Palvimo JJ
    Mol Cell Biol; 2002 Jul; 22(14):5222-34. PubMed ID: 12077349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.